Shares of Biogen Inc. BIIB shed 2.06% to $160.85 Tuesday, on what proved to be an all-around mixed trading session for the ...

Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the ...

Box, Inc. (NYSE:BOX), the leading Intelligent Content Management (ICM) platform, today announced preliminary financial ...

TOKYO: Japan’s Nikkei share average edged down on Wednesday, with investors booking profit after two straight days of gains ...

After about five years working behind the scenes, Arrakis Therapeutics is unveiling that its lead program will aim to treat ...

A maker of drug-device combination products with a St. Louis-based unit undergoing a $100 million expansion has named an IT ...

The article summarizes current notable health news, including Biogen's Alzheimer's drug growth, mysterious disease in Congo, ...

The article summarizes recent developments in the health sector, including Biogen's Alzheimer's drug growth, Idaho's abortion ...

Roku's stock surged 10% on potential buyout news. Analysts believe the company's data assets and market position make it an ...

The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss ...

"We think the sale of all these cryptocurrency holdings for shareholder return and business development proves Meitu's ...

Jefferies started coverage on Coherent Inc (NYSE: COHR) with a “buy” rating, giving stock a target price of $135, citing ...